Manufacturing - Specialty Pharma

Global biopharmaceutical company, Paris-listed Ipsen, has agreed to acquire ImCheck Therapeutics, a private French biotechnology company pioneering next-generation immuno-oncology therapies. Under the terms of the agreement,...

Media reports point to PAI Partners selling Ethypharm, a France-based pharmaceutical company with a focus on hospital injectables, pain and addiction treatment, for more than...

Kent-Athlone Pharma Group, a UK-based specialty European pharmaceuticals company, has appointed Olga Lund as CFO. Lund brings over 20 years of experience in the pharmaceuticals industry, following an...

Switzerland-based multinational pharmaceutical company Novartis is acquiring Nasdaq-listed Tourmaline Bio, a US-based clinical-stage biopharmaceutical company focused on developing pacibekitug, an anti-IL-6 mAb, as a treatment...

AnaCardio, a Swedish clinical-stage biopharmaceutical company focusing on developing novel drugs to treat patients with heart failure, has appointed Philipp Mathieu as CFO. Mathieu is...

Euronext and Nasdaq-listed Pharming Group, a global biopharmaceutical company, has appointed Kenneth Lynard as CFO, effective 1 October 2025. His appointment strengthens the firm’s...

International private equity firms, Bain Capital and Cinven, have signed a definitive agreement to sell a majority stake in STADA Arzneimittel, a healthcare and...

Anocca, a Sweden-based clinical-stage T-cell immunotherapy company, has successfully raised SEK440m (US$46m) in financing led by Mellby Gård with strong support from AMF, Ramsbury...

Allan Watson, Kelso Pharma’s CFO, has decided to retire from his role and is being succeeded by life sciences financial specialist, Alan King. Watson is...

France-based SERB Pharmaceuticals, a global specialty pharmaceutical company focused on medicines for rare diseases and medical emergencies, is acquiring Nasdaq-listed Y-mAbs Therapeutics, a US-based...